The Maharashtra FDA has cancelled the production license of Johnson & Johnson's in Mumbai and ordered it to recall its stock from the market. The serious steps come as a result of the FDA's sample tests that were conducted in 2018 and 2019, which found that the talc-based baby powder has a pH value above the mandated levels.
NEW YORK, Feb 5 Johnson & Johnson (J&J) created a plan last year to limit the financial bleeding from billions of dollars in jury awards to plaintiffs who alleged the company’s Baby Powder and other talc products caused deadly cancers. The healthcare and consumer-goods giant assigned.